Mark Stares

发表

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Nicolai J. Birkbak, Angela E. Leek, R. Booton, 2017, Immunity.

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

P. A. Futreal, Z. Szallasi, I. Csabai, 2018, Cell.

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

Francesco Favero, Ignacio Varela, Charles Swanton, 2014, Genome Biology.

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

G. Mayhew, T. Richmond, S. Horswell, 2018, Cell.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Zoltan Szallasi, Ashish Chandra, Adam Huffman, 2018, Cell.

How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?

C. Swanton, M. Stares, J. Larkin, 2015, Current opinion in urology.

Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapy

M. Tivers, Marie E. Mathers, Alison Meynert, 2024, medRxiv.

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution

I. Varela, S. Horswell, J. Larkin, 2015, Nature Communications.